• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于地理位置的肝细胞癌治疗差异正在缩小。

Disparities in the treatment of hepatocellular carcinoma based on geographical region are decreasing.

机构信息

Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.

Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, Ohio, USA.

出版信息

J Gastroenterol Hepatol. 2019 Mar;34(3):575-579. doi: 10.1111/jgh.14515. Epub 2018 Nov 18.

DOI:10.1111/jgh.14515
PMID:30345600
Abstract

BACKGROUND AND AIM

Geographic differences have existed in the management of hepatocellular carcinoma (HCC), and efforts to reduce regional disparities have been initiated. The aim of this study is to use the Nationwide Inpatient Sample to determine if regional disparities in the treatment of HCC continue to exist.

METHOD

A retrospective database analysis using the Nationwide Inpatient Sample was performed that included patients with a primary diagnosis of HCC. Logistic regression models were utilized to determine geographic disparities in liver decompensation, treatment, inpatient mortality, and metastatic disease.

RESULTS

This study's locational reach of 62 604 patients included 22 769 patients from the South (36%), 14 554 in the Northeast (23%), 14 041 in the West (22%), and 11 240 in the Midwest (18%). Patients who received treatment in the West were more likely to have inpatient mortality (OR 1.28, 95% CI 1.03, 1.53) than patients who received treatment in the Midwest. No significant differences were observed between rates of resection, ablation, and transarterial chemoembolization when comparing by region. Rates of liver transplantation were lower in the West compared with the Midwest (OR 0.51, 95% CI 0.29, 0.87). There was no significant difference between other regions.

CONCLUSION

Geographic disparities in the treatment of HCC are improving.

摘要

背景与目的

肝细胞癌(HCC)的治疗存在地域差异,为减少地域差异已开展相关工作。本研究旨在利用全国住院患者样本(Nationwide Inpatient Sample,NIS)确定 HCC 治疗的地域差异是否仍然存在。

方法

使用 NIS 进行回顾性数据库分析,纳入 HCC 主要诊断的患者。采用 logistic 回归模型确定肝失代偿、治疗、住院死亡率和转移性疾病的地域差异。

结果

本研究的地域范围涉及 62604 例患者,其中南方患者 22769 例(36%)、东北患者 14554 例(23%)、西部患者 14041 例(22%)和中西部患者 11240 例(18%)。与中西部地区相比,接受西部地区治疗的患者住院死亡率更高(OR 1.28,95%CI 1.03,1.53)。按地域比较时,手术切除、消融和经动脉化疗栓塞的比例没有显著差异。与中西部相比,西部地区的肝移植率较低(OR 0.51,95%CI 0.29,0.87)。其他地区之间无显著差异。

结论

HCC 治疗的地域差异正在改善。

相似文献

1
Disparities in the treatment of hepatocellular carcinoma based on geographical region are decreasing.基于地理位置的肝细胞癌治疗差异正在缩小。
J Gastroenterol Hepatol. 2019 Mar;34(3):575-579. doi: 10.1111/jgh.14515. Epub 2018 Nov 18.
2
Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.社会经济学、手术治疗与早期肝细胞癌生存率的关联
J Surg Res. 2017 Apr;210:253-260. doi: 10.1016/j.jss.2016.11.042. Epub 2016 Nov 30.
3
Temporal trends of health disparity in the utilization of curative-intent treatments for hepatocellular carcinoma: are we making progress?肝细胞癌治疗方法应用中的健康差距的时间趋势:我们是否在取得进展?
J Gastrointest Surg. 2024 Sep;28(9):1392-1399. doi: 10.1016/j.gassur.2024.05.015. Epub 2024 May 14.
4
Insurance status impacts treatment for hepatocellular carcinoma.保险状况影响肝细胞癌的治疗。
Ann Hepatol. 2019 May-Jun;18(3):461-465. doi: 10.1016/j.aohep.2018.10.001. Epub 2019 Apr 12.
5
Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.经动脉化疗栓塞联合射频消融治疗早期肝细胞癌。
Korean J Intern Med. 2016 Mar;31(2):242-52. doi: 10.3904/kjim.2015.112. Epub 2016 Feb 15.
6
Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.巴塞罗那临床肝癌分期0/A期切除术后复发性肝细胞癌经动脉化疗栓塞术与射频消融术的回顾性对比研究
J Vasc Interv Radiol. 2016 Dec;27(12):1829-1836. doi: 10.1016/j.jvir.2016.06.010. Epub 2016 Aug 21.
7
Impact of geographic disparity on liver allocation for hepatocellular cancer in the United States.美国肝癌肝分配的地理差异影响。
J Hepatol. 2012 Mar;56(3):618-25. doi: 10.1016/j.jhep.2011.08.019. Epub 2011 Oct 23.
8
Trends and outcomes of transarterial chemoembolization in hepatocellular carcinoma: a national survey.经导管动脉化疗栓塞治疗肝细胞癌的趋势和结局:全国性调查。
Hepatobiliary Pancreat Dis Int. 2017 Dec 15;16(6):624-630. doi: 10.1016/S1499-3872(17)60077-8.
9
Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.对于经动脉化疗栓塞后降期的初始不可切除肝细胞癌患者,挽救性肝切除是否必要?十年经验。
Oncologist. 2016 Dec;21(12):1442-1449. doi: 10.1634/theoncologist.2016-0094. Epub 2016 Aug 2.
10
Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma.肝细胞癌手术治疗应用中的种族和地理差异。
J Gastrointest Surg. 2007 Dec;11(12):1636-46; discussion 1646. doi: 10.1007/s11605-007-0315-8. Epub 2007 Oct 3.

引用本文的文献

1
Geographic disparities in access to liver transplantation.肝脏移植可及性的地域差异。
Liver Transpl. 2023 Sep 1;29(9):987-997. doi: 10.1097/LVT.0000000000000182. Epub 2023 May 29.
2
Epidemiologic, humanistic and economic burden of hepatocellular carcinoma in the USA: a systematic literature review.美国肝细胞癌的流行病学、人文和经济负担:一项系统文献综述
Hepat Oncol. 2020 Jul 21;7(3):HEP27. doi: 10.2217/hep-2020-0024.